While there are a significant number of studies illustrating the relationship between IP-10, MCP-1, MIP-1α, and IL-6, and COVID-19 disease severity in other countries, evaluating these cytokines in a population, where the COVID-19 morbidity and mortality rates have been very low, could add a different perspective to evolving understanding of COVID-19 disease pathogenesis and treatment. The gene discussed is CCL3; the disease is COVID-19.